641 related articles for article (PubMed ID: 29902542)
1. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial.
Gomez-Villa R; Aguilar-Rebolledo F; Lozano-Platonoff A; Teran-Soto JM; Fabian-Victoriano MR; Kresch-Tronik NS; Garrido-Espíndola X; Garcia-Solis A; Bondani-Guasti A; Bierzwinsky-Sneider G; Contreras-Ruiz J
Wound Repair Regen; 2014; 22(4):497-503. PubMed ID: 25041620
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Topical Recombinant Human Epidermal Growth Factor for Treatment of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis.
Yang S; Geng Z; Ma K; Sun X; Fu X
Int J Low Extrem Wounds; 2016 Jun; 15(2):120-5. PubMed ID: 27151755
[TBL] [Abstract][Full Text] [Related]
4. Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials.
Yang Q; Zhang Y; Yin H; Lu Y
Ann Vasc Surg; 2020 Jan; 62():442-451. PubMed ID: 31394225
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of recombinant human epidermal growth factor for diabetic foot ulcers: A systematic review and meta-analysis of randomised controlled trials.
Zhao DY; Su YN; Li YH; Yu TQ; Li J; Tu CQ
Int Wound J; 2020 Aug; 17(4):1062-1073. PubMed ID: 32343054
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal growth factor enhances healing of diabetic foot ulcers.
Tsang MW; Wong WK; Hung CS; Lai KM; Tang W; Cheung EY; Kam G; Leung L; Chan CW; Chu CM; Lam EK
Diabetes Care; 2003 Jun; 26(6):1856-61. PubMed ID: 12766123
[TBL] [Abstract][Full Text] [Related]
7. Epidermal Growth Factor is Effective in the Treatment of Diabetic Foot Ulcers: Meta-Analysis and Systematic Review.
Bui TQ; Bui QVP; Németh D; Hegyi P; Szakács Z; Rumbus Z; Tóth B; Emri G; Párniczky A; Sarlós P; Varga O
Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31331038
[TBL] [Abstract][Full Text] [Related]
8. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
[TBL] [Abstract][Full Text] [Related]
9. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study.
Fernández-Montequín JI; Valenzuela-Silva CM; Díaz OG; Savigne W; Sancho-Soutelo N; Rivero-Fernández F; Sánchez-Penton P; Morejón-Vega L; Artaza-Sanz H; García-Herrera A; González-Benavides C; Hernández-Cañete CM; Vázquez-Proenza A; Berlanga-Acosta J; López-Saura PA;
Int Wound J; 2009 Dec; 6(6):432-43. PubMed ID: 20051095
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology promotes the full-thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats.
Chu Y; Yu D; Wang P; Xu J; Li D; Ding M
Wound Repair Regen; 2010; 18(5):499-505. PubMed ID: 20840519
[TBL] [Abstract][Full Text] [Related]
11. Granulation response and partial wound closure predict healing in clinical trials on advanced diabetes foot ulcers treated with recombinant human epidermal growth factor.
Valenzuela-Silva CM; Tuero-Iglesias ÁD; García-Iglesias E; González-Díaz O; Del Río-Martín A; Yera Alos IB; Fernández-Montequín JI; López-Saura PA
Diabetes Care; 2013 Feb; 36(2):210-5. PubMed ID: 22966096
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ
J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the combination of isosorbide dinitrate spray and chitosan gel for the treatment of diabetic foot ulcers: A double-blind, randomized, clinical trial.
Totsuka Sutto SE; Rodríguez Roldan YI; Cardona Muñoz EG; Garcia Cobian TA; Pascoe Gonzalez S; Martínez Rizo A; Mendez Del Villar M; García Benavides L
Diab Vasc Dis Res; 2018 Jul; 15(4):348-351. PubMed ID: 29682995
[TBL] [Abstract][Full Text] [Related]
15. The beneficial effects of probiotic administration on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
Mohseni S; Bayani M; Bahmani F; Tajabadi-Ebrahimi M; Bayani MA; Jafari P; Asemi Z
Diabetes Metab Res Rev; 2018 Mar; 34(3):. PubMed ID: 29193662
[TBL] [Abstract][Full Text] [Related]
16. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial.
Squadrito F; Bitto A; Altavilla D; Arcoraci V; De Caridi G; De Feo ME; Corrao S; Pallio G; Sterrantino C; Minutoli L; Saitta A; Vaccaro M; Cucinotta D
J Clin Endocrinol Metab; 2014 May; 99(5):E746-53. PubMed ID: 24483158
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human epidermal growth factor (REGEN-D 150): effect on healing of diabetic foot ulcers.
Mohan VK
Diabetes Res Clin Pract; 2007 Dec; 78(3):405-11. PubMed ID: 17655964
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
Wieman TJ; Smiell JM; Su Y
Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
[TBL] [Abstract][Full Text] [Related]
19. Magnesium Supplementation and the Effects on Wound Healing and Metabolic Status in Patients with Diabetic Foot Ulcer: a Randomized, Double-Blind, Placebo-Controlled Trial.
Razzaghi R; Pidar F; Momen-Heravi M; Bahmani F; Akbari H; Asemi Z
Biol Trace Elem Res; 2018 Feb; 181(2):207-215. PubMed ID: 28540570
[TBL] [Abstract][Full Text] [Related]
20. Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
Fernández-Montequín JI; Infante-Cristiá E; Valenzuela-Silva C; Franco-Pérez N; Savigne-Gutierrez W; Artaza-Sanz H; Morejón-Vega L; González-Benavides C; Eliseo-Musenden O; García-Iglesias E; Berlanga-Acosta J; Silva-Rodríguez R; Betancourt BY; López-Saura PA;
Int Wound J; 2007 Dec; 4(4):333-43. PubMed ID: 17953679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
